Calcium channel blockers: do they have pleiotropic effects on atherosclerosis?

Perez, IF Soltero
April 2000
Journal of Human Hypertension;Apr2000 Supplement, Vol. 14 Issue 4, pS96
Academic Journal
Since 1980, calcium channel blockers (CCBs) have been used effectively to lower high blood pressure (HBP). Flekestein proposed that CCBs could be used to avoid calcium deposition on the arterial wall, one of the main components of atherosclerosis. This is also called ectopic calcium. This review briefly looks over the current role of CCBs in atherosclerosis and the future based on human trials still in progress.


Related Articles

  • BP should be ultra low in CAD.  // Cortlandt Forum;1/25/2005, Vol. 18 Issue 1, p18 

    Discusses the results of a study on the use of calcium channel block to coronary artery disease (CAD)patients with normal blood pressure. Blood pressure range of CAD patients; Cardiovascular mortality with atenolol; Progression of atherosclerosis in the placebo group.

  • The Effect of Antihypertensive Drugs on Carotid Intima Media Thickness: An Up-to-Date Review. Riccioni, Graziano // Current Medicinal Chemistry;Mar2009, Vol. 16 Issue 8, p988 

    Atherosclerosis and hypertension are two important pathological vascular processes which share a crucial common pathway: an altered vascular homeostasis characterized by endothelial dysfunction. Carotid intima-media thickness (CIMT) measured by ultrasound has been shown to correlate with the...

  • Glomeruloprotection Varies among Calcium Channel Blockers.  // Kidney;Nov/Dec99, Vol. 8 Issue 6, p231 

    Reports on the measurement of the relative ability of three classes of calcium channel blockers (CCB) to provide renoprotection in the rat model. Linear correlation between the average blood pressure (BP) and glomerulosclerosis in all groups of rats; Reason for class differences in relative...

  • A Factorial Study of Combination Hypertension Treatment With Metoprolol Succinate Extended Release and Felodipine Extended Release: Results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT) Frishman, William H.; Hainer, James W.; Sugg, Jennifer // American Journal of Hypertension;Apr2006, Vol. 19 Issue 4, p388 

    Background: Many hypertensive patients require combination therapy to achieve target blood pressure (BP). β-Blockers and dihydropyridine calcium channel blockers are effective as monotherapy in hypertensive patients and have complementary mechanisms for lowering BP. Methods: This multicenter,...

  • 'Stairway of care' leads to cut in hypertension.  // Primary Health Care;Jul/Aug2002, Vol. 12 Issue 6, p7 

    Discusses research being done on the effect of blood pressure reduction with calcium channel blocker on coronary heart disease in the United Kingdom and Ireland. Methodology of the study; Discussion on findings; Role of nurses.

  • The Author Replies:. Bakris, George L // Kidney International;Jul2013, Vol. 84 Issue 1, p215 

    A response from the author of the article regarding the Olmesartan and Calcium Antagonists Randomized (OSCAR) trial in the July 2013 issue, which discusses the effects of different blood pressure levels on kidney disease progression, is presented.

  • Oral Nifedipine in the Treatment of Chronic Anal Fissure. N. Ağaoğlu; S. Cengiz; M.K. Arslan; S. Türkyılmaz // Digestive Surgery;2003, Vol. 20 Issue 5, p452 

    Background: The purpose of this study was to demonstrate the effect of oral nifedipine on maximal resting anal pressure (MRAP) in healthy volunteers and to evaluate its role in the treatment of chronic anal fissure (CAF). Methods: MRAP was measured in 10 healthy volunteers and 10 patients with...

  • Lercanidipine and labedipinedilol-A play anti-inflammatory role through inhibition of lipopolysaccharide/interferon-γ-induced HMGB1 release and MMP-2,9 activities in vascular smooth muscle cells. Liou, S.; Shih, M.; Chen, C. // Proceedings of the Physiological Society;2013, p604P 

    Inflammation is an important molecular basis of atherosclerosis. Several reports have revealed that dihydropyridine calcium channel blockers (CCBs) exert anti-inflammatory effects on various vascular cells. The purpose of the present study was to evaluate anti-inflammatory effects and mechanisms...

  • What is the optimal blood pressure and drug therapy for patients with coronary artery disease? Pepine, Carl J. // JAMA: Journal of the American Medical Association;11/10/2004, Vol. 292 Issue 18, p2271 

    Presents an editorial on the optimal blood pressure and drug therapy for patients with coronary artery diseases (CAD). Two large randomized trials which have shed new light on the issue; Findings of the "International Verapamil-trandolapril Study" (INVEST); Findings of the "Comparison of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics